Drug substance (DS) process validation, drug product (DP) process validation, clinical development phase 3, and storage/stability for the program with ultimate goal of U.S. F.D.A. Licensure of bont…
Ended Awarded Last action
- Contract number
- W911SR23F0057
- Awardee
-
Resilience Government Services, Inc. UEI GC2RFAZK8G64
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $4,278,565
Award facts
- Opportunity
-
- W911SR22R0040 Solicitation number
- Contract value 47% obligated
-
- $4,278,565.10 Current, with exercised options
- $9,080,310.53 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Santa Fe, FL 32615, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Default | $0 | |
| Funding Only Action | -$414,679 | |
| Other Administrative Action | -$2,200,000 | |
| Funding Only Action | -$2,129,851 | |
| Supplemental Agreement for work within scope | $4,520,687 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $2,176,371 | |
| Other Administrative Action | $135,313 | |
| Other Administrative Action | $400,000 | |
| Other Administrative Action | -$3,290,313 | |
| Funding Only Action | $681,037 | |
| Original award | $4,400,000 |
Show all 12
About this award
Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) was awarded a delivery order valued at $9.08 million by the Joint Program Executive Office for Chemical and Biological Defense to advance development of a monoclonal antibody countermeasure against botulinum neurotoxin exposure. The delivery order, issued on March 7, 2023, with completion targeted for December 30, 2025, encompasses drug substance process validation, drug product process validation, Phase 3 clinical development, and storage/stability testing activities directed toward U.S. Food and Drug Administration licensure of the BONT mAb G03-52-01 drug product. The contract is structured as a cost-plus-fixed-fee delivery order with no set-aside designation and will be performed in Alachua, Florida.
This award falls under Resilience's larger $249 million single-award Indefinite Delivery Contract with the Department of the Army's Acquisition Support Center, which serves as the primary acquisition vehicle for FDA-approved products supporting chemical and biological defense programs. Resilience, founded in 2020, is a biomanufacturing company focused on developing complex medical countermeasures against biological threats. The company has demonstrated expertise across the development pipeline through prior federal contract performance, including clinical trial execution, process development and validation, and manufacturing scale-up activities for medical countermeasures, positioning it to successfully advance this monoclonal antibody program toward regulatory approval.
Description
Drug substance (DS) process validation, drug product (DP) process validation, clinical development phase 3, and storage/stability for the program with ultimate goal of U.S. F.D.A. Licensure of bont MAB G03-52-01 drug product.
Quick answers
Who was awarded contract W911SR23F0057?
W911SR23F0057 was awarded to Resilience Government Services, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on March 7, 2023.
How much is contract W911SR23F0057 worth?
The government has obligated $4,278,565 on W911SR23F0057. Its potential value, with all options, is $9,080,311.
Which agency awarded contract W911SR23F0057?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR23F0057, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Is contract W911SR23F0057 an order under another contract?
Yes. W911SR23F0057 is a delivery order under W911SR22D0009, an indefinite delivery contract.
Was contract W911SR23F0057 competed?
The extent of competition for W911SR23F0057 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award